Clinical Trials Browser

Phase 2 × Terminated × bavituximab × Clear all

NCT05249569 2023-05-03

Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma

Phase 2 Terminated

1 enrolled 4 charts

Gastrointestinal

Carcinoma, Hepatocellular